ACOX2
Basic information
Region (hg38): 3:58505136-58537283
Links
Phenotypes
GenCC
Source:
- congenital bile acid synthesis defect 6 (Limited), mode of inheritance: AR
- congenital bile acid synthesis defect 6 (Moderate), mode of inheritance: AR
- congenital bile acid synthesis defect 6 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bile acid synthesis defect, congenital, 6 | AR | Gastrointestinal | Individuals have been described with hepatic dysfunction, and avoidance of hepatotoxic agents and medical management (eg, with cholestyramine) has been described as beneficial | Gastrointestinal | 27647924; 27884763 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACOX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 44 | 49 | ||||
missense | 88 | 98 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 10 | 14 | |||
non coding | 21 | 28 | ||||
Total | 0 | 0 | 95 | 73 | 14 |
Variants in ACOX2
This is a list of pathogenic ClinVar variants found in the ACOX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-58505214-G-A | ACOX2-related disorder | Likely benign (Mar 14, 2023) | ||
3-58505271-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
3-58505275-G-A | ACOX2-related disorder | Likely benign (May 25, 2022) | ||
3-58505276-G-T | not specified | Uncertain significance (Jun 09, 2022) | ||
3-58505278-A-C | Likely benign (Mar 31, 2018) | |||
3-58505281-G-A | Likely benign (Sep 02, 2022) | |||
3-58505283-TCTC-T | Uncertain significance (Sep 13, 2022) | |||
3-58505295-A-G | Likely benign (Aug 10, 2022) | |||
3-58505304-C-T | Likely benign (Jul 17, 2023) | |||
3-58508886-C-G | ACOX2-related disorder | Likely benign (Sep 12, 2023) | ||
3-58508886-C-T | ACOX2-related disorder | Likely benign (Jun 10, 2024) | ||
3-58508943-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-58508944-G-A | ACOX2-related disorder | Likely benign (Oct 20, 2023) | ||
3-58508949-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
3-58508953-A-G | ACOX2-related disorder | Likely benign (Jan 02, 2024) | ||
3-58508974-T-G | not specified | Uncertain significance (Jun 18, 2021) | ||
3-58508981-T-C | not specified | Uncertain significance (Jul 30, 2023) | ||
3-58509024-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
3-58509029-G-A | Likely benign (May 28, 2022) | |||
3-58509039-CAA-C | Likely benign (Mar 07, 2023) | |||
3-58517191-GTC-G | Likely benign (Jan 02, 2024) | |||
3-58517206-C-T | Uncertain significance (Jan 26, 2023) | |||
3-58517207-G-A | ACOX2-related disorder | Uncertain significance (Jun 22, 2024) | ||
3-58517216-G-A | Benign (Nov 07, 2023) | |||
3-58517235-T-C | Likely benign (Nov 24, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACOX2 | protein_coding | protein_coding | ENST00000302819 | 14 | 32184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.18e-10 | 0.965 | 125082 | 0 | 666 | 125748 | 0.00265 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.502 | 387 | 416 | 0.931 | 0.0000253 | 4427 |
Missense in Polyphen | 118 | 134 | 0.88062 | 1429 | ||
Synonymous | 0.521 | 159 | 168 | 0.949 | 0.0000105 | 1362 |
Loss of Function | 2.16 | 21 | 34.8 | 0.604 | 0.00000157 | 393 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00208 | 0.00208 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000545 | 0.000544 |
Finnish | 0.00883 | 0.00886 |
European (Non-Finnish) | 0.00276 | 0.00276 |
Middle Eastern | 0.000545 | 0.000544 |
South Asian | 0.00291 | 0.00291 |
Other | 0.00245 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: Oxidizes the CoA esters of the bile acid intermediates di- and tri-hydroxycholestanoic acids. {ECO:0000269|PubMed:27884763}.;
- Pathway
- Peroxisome - Homo sapiens (human);Primary bile acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);27-Hydroxylase Deficiency;Bile Acid Biosynthesis;Congenital Bile Acid Synthesis Defect Type II;Cerebrotendinous Xanthomatosis (CTX);Zellweger Syndrome;Familial Hypercholanemia (FHCA);Congenital Bile Acid Synthesis Defect Type III;Quercetin and Nf-kB- AP-1 Induced Cell Apoptosis;PPAR signaling pathway;Metabolism of lipids;Metabolism of proteins;Tyrosine metabolism;Leukotriene metabolism;Beta-oxidation of pristanoyl-CoA;Omega-3 fatty acid metabolism;Saturated fatty acids beta-oxidation;Trihydroxycoprostanoyl-CoA beta-oxidation;Peroxisomal lipid metabolism;Metabolism;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Peroxisomal protein import;Fatty acid metabolism;Metabolism of steroids;Omega-6 fatty acid metabolism;Bile acid biosynthesis;Putative anti-Inflammatory metabolites formation from EPA;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);bile acid biosynthesis, neutral pathway
(Consensus)
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- loftool
- 0.712
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.96
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.190
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.175
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acox2
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- protein targeting to peroxisome;bile acid biosynthetic process;positive regulation of cell death;fatty acid beta-oxidation using acyl-CoA oxidase;lipid homeostasis;positive regulation of response to oxidative stress
- Cellular component
- peroxisome;peroxisomal matrix;cytosol;intracellular membrane-bounded organelle
- Molecular function
- acyl-CoA oxidase activity;signaling receptor binding;fatty acid binding;pristanoyl-CoA oxidase activity;3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity;protein homodimerization activity;flavin adenine dinucleotide binding;FAD binding